First year experience of rotavirus immunisation programme in Finland.
暂无分享,去创建一个
J. Ollgren | T. Leino | T. Kilpi | H. Salo | Petri Tiihonen
[1] A. Garcia-Basteiro,et al. Hospitalizations due to rotavirus gastroenteritis in Catalonia, Spain, 2003-2008 , 2011, BMC Research Notes.
[2] J. Hadler,et al. Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006-2008. , 2011, Vaccine.
[3] A. Curns,et al. Effectiveness of Pentavalent Rotavirus Vaccine Against Severe Disease , 2011, Pediatrics.
[4] E. Oger,et al. Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: the IVANHOE study. , 2011, Vaccine.
[5] P. van Damme,et al. Rotavirus Vaccines in Belgium: Policy and Impact , 2011, The Pediatric infectious disease journal.
[6] E. Shapiro,et al. Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA. , 2010, Vaccine.
[7] V. Baldo,et al. Hospitalisation for rotavirus gastroenteritis in the paediatric population in the Veneto Region, Italy , 2010, BMC public health.
[8] Manish M Patel,et al. Effectiveness of Pentavalent Rotavirus Vaccine in a Large Urban Population in the United States , 2010, Pediatrics.
[9] M. Kundi,et al. Universal Mass Vaccination Against Rotavirus Gastroenteritis: Impact on Hospitalization Rates in Austrian Children , 2009, The Pediatric infectious disease journal.
[10] Manish M Patel,et al. Decline and Change in Seasonality of US Rotavirus Activity After the Introduction of Rotavirus Vaccine , 2009, Pediatrics.
[11] M. Dinubile,et al. Decline in Cases of Rotavirus Gastroenteritis Presenting to The Children's Hospital of Philadelphia after Introduction of a Pentavalent Rotavirus Vaccine , 2009, Clinical and Vaccine Immunology.
[12] Felix Espinoza,et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study , 2008, The Lancet.
[13] T. Vesikari,et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study , 2007, The Lancet.
[14] T. Vesikari,et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.
[15] J. Heyse,et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.
[16] Timo Vesikari,et al. Burden of Rotavirus Disease in European Union Countries , 2006, The Pediatric infectious disease journal.
[17] T. Vesikari,et al. Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants , 2004, The Pediatric infectious disease journal.
[18] Mark A. Miller,et al. Global Illness and Deaths Caused by Rotavirus Disease in Children , 2003, Emerging infectious diseases.
[19] C. von Bonsdorff,et al. Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.